Sponsor or institution
Clinical trials and research at Bedrock Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Stopping corneal transplant rejection with BDRK-401 gene therapy
A one-time gene treatment is applied to donor corneas to help people at high risk keep their corneal transplants from being rejected.
-
Preventing corneal transplant rejection with a new gene therapy
This study is testing a new gene therapy to help prevent the rejection of corneal transplants, which could be a game-changer for people with corneal blindness, by treating the donor tissue before surgery to keep it safe from the recipient's immune system.
-
Designing new AAV vectors to target liver cells and avoid immune response
This study is working on a new way to deliver gene therapy directly to liver cells while avoiding the body's immune response, which could lead to better treatment options for people with liver diseases.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.